Showing results (1271-1280 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|September 6, 2008
Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assayNimi Marcel, Ajay Nahta, Meenakshi BalganeshChemotherapy|September 5, 2008
Anticancer properties of 2-piperidyl analogues of the natural indole phytoalexin 1-methoxyspirobrassinolRoman Mezencev, Peter Kutschy, Aneta Salayová, et al.Chemotherapy|January 1, 1991
In vitro and in vivo candicidal activities of 2-(p-n-hexylphenylamino)-1,3-thiazolineR J Baumann, G D Mayer, L D Fite, et al.Chemotherapy|January 1, 1991
In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobialsS M Qadri, G C Lee, M E EllisChemotherapy|January 1, 1991
Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitroM Morimoto, H Mori, T Otake, et al.Chemotherapy|August 17, 2005
Current guidelines for the treatment of severe pneumonia and sepsisK F BodmannChemotherapy|August 17, 2005
Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant Gram-positive bacteriaFlavia Huygens, John F O'Sullivan, Constance E J van RensburgChemotherapy|January 1, 1992
Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalisT Yamada, Y Yokota, F Ikeda, et al.Chemotherapy|January 11, 1992
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patientsV Krcméry, I Koza, J Mardiak, et al.Chemotherapy|January 1, 1992
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosisR Orlando, A Sawadogo, P A Miglioli, et al.Pageof 308